![]() | ||
Molecular
Diagnostic Laboratory |
||
|
Department of Molecular Medicine, Aarhus University Hospital Skejby |
||
|
2011 | 2010 | 2009 | 2008| 2005 -2007 | 1996- 2004| By author | Supplementary data | NormFinder |Graduations |
||
|
2006 According to JCR Science Edition 2005, the total impact factor of these 21 publications is 140, with 17 publications with an impact factor above 2.5. Aaboe M, Birkenkamp-Demtroder K, Wiuf C, Sørensen FB, Thykjaer T, Sauter G, Møller-Ernst Jensen K, Dyrskjøt L, Ørntoft TF. SOX4 expression in bladder carcinoma: clinical aspects and in vitro functional characterization. Cancer Research. 2006. Apr 1;66(7):3434-42. PubMed Suppl Data Andersen CL, Wiuf C, Kruhoffer M, Korsgaard M, Laurberg, S and Orntoft TF. Frequent occurrence of uniparental disomy in colorectal cancer. Carcinogenesis. 2007 Jan;28(1):38-48. Epub 2006 Jun 13. PubMed Andersen JB, Aaboe M, Borden EC, Goloubeva OG, Hassel BA,
Ørntoft TF. Stage-associated overexpression of the ubiquitin-like
protein, ISG15, in bladder cancer. Br J Cancer. 2006 May 22;94(10):1465-71.
PubMed Dahl C, Saito H, Kruhoffer M, Schiotz Ebbesen LS, Olesen SH, Kruhoffer M, Ingerslev J, Orntoft
TF. Folate deficiency induced hyperhomocysteinemia changes
the expression of thrombosis-related genes. Blood Coagul Fibrinolysis.
2006 Jun;17(4):293-301. PubMed Frohlich C, Albrechtsen R, Dyrskjot L, Rudkjaer L,
Orntoft TF, Wewer UM. Molecular Profiling of ADAM12 in Human Bladder Cancer. Clin Cancer Res. 2006
Dec 15;12(24):7359-7368. PubMed Gaustadnes M, Orntoft TF, Jensen JL, Torring N. Validation
of the use of DNA pools and primer extension in association studies
of sporadic colorectal cancer for selection of candidate SNPs. Hum Mutat.
2006 Feb;27(2):187-94. PubMed Holten-Andersen MN, Brunner N, Nielsen HJ, Christensen
IJ, Sorensen NM, Rasmussen AS, Primdahl H, Orntoft T.
Levels of tissue inhibitor of metalloproteinases Lamy P, Andersen CL, Dyrskjot L, Torring N, Orntoft
T, Wiuf C. Are microRNAs located in genomic regions associated with cancer? Br J Cancer.
2006 Nov 20;95(10):1415-8. Epub 2006 Sep 26. PubMed Marcheco-Teruel B, Flint TJ, Wikman FP, Torralbas
M, Gonzalez L, Blanco L, Tan Q, Ewald H, Orntoft T, Kruse TA, Borglum
AD, Mors O. A genome-wide linkage search for
bipolar disorder susceptibility loci in a large and complex pedigree
from the eastern part of Memon AA, Sorensen BS, Meldgaard P, Fokdal L, Thykjaer
T, Nexo E. The relation between survival and expression of HER1 and HER2 depends on the
expression of HER3 and HER4: a study in bladder cancer patients. Br
J Cancer. 2006 Jun 5;94(11):1703-9. PubMed Nielsen K, Vorum H, Fagerholm P, Birkenkamp-Demtroder
K, Honore B, Ehlers N, Orntoft TF. Proteome Profiling
of Corneal Epithelium and Identification of Marker Proteins for Keratoconus,
a pilot study. Exp Eye Res. 2006 Feb;82(2):201-9. Epub 2005 Aug 3. PubMed
Orntoft TF, Zieger K, Dyrskjot L. Recent developments in molecular profiling of bladder cancer. Curr Opin
Urol. 2006 Sep;16(5):377-81. Review. PubMed Ropero S, Fraga MF, Ballestar E, Hamelin R, Yamamoto
H, Boix-Chornet M, Caballero R, Alaminos M, Setien F, Paz MF, Herranz
M, Palacios J, Arango D, Orntoft TF, Aaltonen Tort F, Bartkova J, Sehested M, Orntoft T, Lukas J,
Bartek J. Retinoblastoma pathway defects show differential ability to activate the constitutive
DNA damage response in human tumorigenesis. Vanharanta S, Pollard PJ, Lehtonen HJ, Laiho P, Sjoberg
J, Leminen A, Aittomaki K, Arola J, Kruhoffer M, Orntoft TF, Tomlinson
IP, Kiuru M, Arango D, Aaltonen Ylisaukko-Oja SK, Cybulski C, Lehtonen R, Kiuru M, Matyjasik J, Szymanska
A, Szymanska-Pasternak J, Dyrskjot L, Butzow R, Orntoft TF, Launonen
V, Lubinski J, Aaltonen LA. |
||
|
|
||
|
|
||
|
MOMA,
Aarhus University Hospital, Brendstrupgårdsvej 100, 8200
Aarhus N, Denmark | ||